Efficacy and safety of venetoclax-cytarabine-homoharringtonine-based cytoreductive therapy before allogeneic hematopoietic stem cell transplantation in refractory/relapsed acute myeloid leukemia with RUNX1::RUNX1T1: a retrospective study

Venclexta (venetoclax) - Roche, AbbVie

Synribo (omacetaxine mepesuccinate) - Teva

cytarabine - Generic mfg.

http://www.ncbi.nlm.nih.gov/pubmed/41839632

C H Jiang; C W Jin; H Y Lu; J Y Huang; L X Wang; S Li; X X Hu; Z L Zhang

Mar 17, 2026